XBiotech Inc. - Common Shares, no par value (XBIT)

Historical Holders from Q2 2015 to Q3 2025

Symbol
XBIT on Nasdaq
Type / Class
Equity / Common Shares, no par value
Shares outstanding
30.8M
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
2.94M
Holdings value
$7.81M
% of all portfolios
0%
Grand Portfolio weight change
0%
Number of holders
45
Number of buys
15
Number of sells
-29
Average Value change %
0%
Average buys %
+0%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of XBiotech Inc. - Common Shares, no par value (XBIT)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
SIMARD JOHN 19.9% $19.6M 6.62M John Simard 31 Dec 2024
MCKENZIE W THORPE 9.71% $8.84M 2.99M W. Thorpe McKenzie 31 Dec 2024

Institutional Holders of XBiotech Inc. - Common Shares, no par value (XBIT)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 2.94M $7.81M -$1.32M $2.66 45
2025 Q2 3.42M $10.1M -$3.23M $2.97 51
2025 Q1 4.48M $14.5M -$783K $3.24 54
2024 Q4 4.72M $18.6M -$1.61M $3.95 52
2024 Q3 4.85M $37.5M +$1.64M $7.73 49
2024 Q2 4.52M $23.2M +$2.72M $5.14 45
2024 Q1 3.99M $32.5M +$4.81M $8.13 45
2023 Q4 3.45M $13.8M +$207K $4.00 38
2023 Q3 3.4M $14M -$309K $4.12 37
2023 Q2 3.48M $20.7M +$5.85M $5.94 38
2023 Q1 2.49M $8.6M -$921K $3.45 35
2022 Q4 2.76M $9.67M -$1.05M $3.51 38
2022 Q3 3.06M $11.1M -$1.6M $3.62 42
2022 Q2 3.36M $18.9M -$4.78M $5.63 50
2022 Q1 4.02M $34.7M -$1.81M $8.64 58
2021 Q4 4.19M $46.7M -$2.79M $11.13 56
2021 Q3 4.33M $56.1M +$4.05M $12.95 62
2021 Q2 4.02M $66.5M -$4.62M $16.56 55
2021 Q1 4.31M $73.9M +$5.96M $17.17 64
2020 Q4 3.98M $62.3M +$385K $15.65 64
2020 Q3 3.95M $75.3M -$5.85M $19.09 68
2020 Q2 4.3M $58.9M -$337K $13.71 64
2020 Q1 4.39M $46.6M -$15.9M $10.62 60
2019 Q4 5.48M $102M +$15.8M $18.67 59
2019 Q3 4.91M $51.4M +$6.01M $10.46 47
2019 Q2 4.41M $33.4M +$13.2M $7.58 42
2019 Q1 2.55M $28.1M +$16.1M $11.02 37
2018 Q4 1.12M $5.68M -$1.9M $5.08 23
2018 Q3 1.53M $4.85M -$1.16M $3.18 21
2018 Q2 1.83M $8.18M -$6.19M $4.48 30
2018 Q1 3.17M $16.9M -$783K $5.35 42
2017 Q4 3.31M $13M -$2.28M $3.94 43
2017 Q3 3.88M $17M +$658K $4.37 45
2017 Q2 3.75M $17.6M -$1.87M $4.70 45
2017 Q1 3.6M $59.3M +$23.9M $16.48 47
2016 Q4 3.46M $35M +$1.31M $10.12 47
2016 Q3 3.29M $44.3M +$5.76M $13.46 47
2016 Q2 2.79M $58.4M +$31.4M $20.92 46
2016 Q1 1.32M $12.5M -$434K $9.45 32
2015 Q4 1.35M $14.7M +$5.65M $10.87 37
2015 Q3 764K $11.4M +$2.97M $14.94 30
2015 Q2 590K $10.6M +$10.6M $18.08 31